In addition, IFNα can directly upregulate the presentation of surface tumor−associated antigens via augmentation of MHC-I molecules, increasing the immunogenicity of tumor cells and making them more vulnerable to identification and subsequent destruction by cytotoxic CD8+ T cells (37). Here, IFNA1 is linked to neoplasm.